SOUKUP, Jiri, Monika MANETHOVA, Vaclav STEJSKAL, Marie NOVAKOVA, Jaroslava DUSKOVA, Helena HORNYCHOVA, Maria HACOVA, Iva STANICZKOVÁ ZAMBO, Tomas ZELINKA, Mikulas KOSAK, Tomas CESAK, David NETUKA, Ales RYSKA and Filip GABALEC. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms. Endocrine Pathology. Totowa: Humana Press INC, 2024, vol. 35, No 1, p. 14-24. ISSN 1046-3976. Available from: https://dx.doi.org/10.1007/s12022-024-09803-6.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms
Authors SOUKUP, Jiri (203 Czech Republic), Monika MANETHOVA (203 Czech Republic), Vaclav STEJSKAL (203 Czech Republic), Marie NOVAKOVA (203 Czech Republic), Jaroslava DUSKOVA (203 Czech Republic), Helena HORNYCHOVA (203 Czech Republic), Maria HACOVA (203 Czech Republic), Iva STANICZKOVÁ ZAMBO (203 Czech Republic, belonging to the institution), Tomas ZELINKA (203 Czech Republic), Mikulas KOSAK (203 Czech Republic), Tomas CESAK (203 Czech Republic), David NETUKA (203 Czech Republic), Ales RYSKA (203 Czech Republic) and Filip GABALEC (203 Czech Republic).
Edition Endocrine Pathology, Totowa, Humana Press INC, 2024, 1046-3976.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30109 Pathology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.400 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12022-024-09803-6
UT WoS 001173128600001
Keywords in English Hand2; dHand; Paraganglioma; Phox2B; GATA3; Neuroendocrine tumors
Tags 14110112, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 3/5/2024 14:46.
Abstract
Hand2 is a core transcription factor responsible for chromaffin cell differentiation. However, its potential utility in surgical pathology has not been studied. Thus, we aimed to investigate its expression in paragangliomas, other neuroendocrine neoplasms (NENs), and additional non-neuroendocrine tumors. We calibrated Hand2 immunohistochemistry on adrenal medulla cells and analyzed H-scores in 46 paragangliomas (PGs), 9 metastatic PGs, 21 cauda equina neuroendocrine tumors (CENETs), 48 neuroendocrine carcinomas (NECs), 8 olfactory neuroblastomas (ONBs), 110 well-differentiated NETs (WDNETs), 10 adrenal cortical carcinomas, 29 adrenal cortical adenomas, 8 melanomas, 41 different carcinomas, and 10 gastrointestinal stromal tumors (GISTs). Both tissue microarrays (TMAs) and whole sections (WSs) were studied. In 171 NENs, previously published data on Phox2B and GATA3 were correlated with Hand2. Hand2 was positive in 98.1% (54/55) PGs, but only rarely in WDNETs (9.6%, 10/104), CENETs (9.5%, 2/21), NECs (4.2%, 2/48), or ONBs (12.5%, 1/8). Any Hand2 positivity was 98.1% sensitive and 91.7% specific for the diagnosis of PG. The Hand2 H-score was significantly higher in primary PGs compared to Hand2-positive WDNETs (median 166.3 vs. 7.5; p < 0.0001). Metastatic PGs were positive in 88.9% (8/9). No Hand2 positivity was observed in any adrenal cortical neoplasm or other non-neuroendocrine tumors, with exception of 8/10 GISTs. Parasympathetic PGs showed a higher Hand2 H-score compared to sympathetic PGs (median H-scores 280 vs. 104, p < 0.0001). Hand2 positivity in NENs serves as a reliable marker of primary and metastatic PG, since other NENs only rarely exhibit limited Hand2 positivity.
Links
LM2023033, research and development projectName: Síť českých biobank
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 1/7/2024 08:55